Search results
Results from the WOW.Com Content Network
The cerebellopontine angle syndrome is a distinct neurological syndrome of deficits that can arise due to the closeness of the cerebellopontine angle to specific cranial nerves. [1] Indications include unilateral hearing loss (85%), speech impediments, disequilibrium, tremors or other loss of motor control.
The cerebellopontine angle (CPA) (Latin: angulus cerebellopontinus) is located between the cerebellum and the pons. [1] The cerebellopontine angle is the site of the cerebellopontine angle cistern. [2] The cerebellopontine angle is also the site of a set of neurological disorders known as the cerebellopontine angle syndrome.
Lateral pontine syndrome, also known as Marie-Foix syndrome or Marie-Foix-Alajouanine syndrome [1] is one of the brainstem stroke syndromes of the lateral aspect of the pons. A lateral pontine syndrome is a lesion which is similar to the lateral medullary syndrome , but because it occurs in the pons , it also involves the cranial nerve nuclei ...
Burning feet syndrome; Burning mouth syndrome; ... Cerebellopontine angle syndrome; Cerebral salt-wasting syndrome; Cervicocranial syndrome; Charcot–Marie–Tooth ...
Central pontine myelinolysis is a neurological condition involving severe damage to the myelin sheath of nerve cells in the pons (an area of the brainstem). It is predominately iatrogenic (treatment-induced), and is characterized by acute paralysis, dysphagia (difficulty swallowing), dysarthria (difficulty speaking), and other neurological symptoms.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Central pontine myelinolysis is a demyelinating disease that causes difficulty with sense of balance, walking, sense of touch, swallowing and speaking. In a clinical setting, it is often associated with transplant or rapid correction of blood sodium. Undiagnosed, it can lead to death or locked-in syndrome.
Pontocerebellar hypoplasia (PCH) is a heterogeneous group of rare neurodegenerative disorders caused by genetic mutations and characterised by progressive atrophy of various parts of the brain such as the cerebellum or brainstem (particularly the pons). [1]